Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(NY: CLDI )

0.2288 -0.0099 (-4.15%)
Official Closing Price Updated: 4:10 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 393,232
Open 0.2399
Bid (Size) 0.2180 (6)
Ask (Size) 0.2270 (25)
Prev. Close 0.2387
Today's Range 0.2155 - 0.2400
52wk Range 0.1435 - 5.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ASP Isotopes and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESSWIRE
Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV
Via ACCESSWIRE

Performance

YTD
-84.11%
-84.11%
1 Month
+37.01%
+37.01%
3 Month
-76.92%
-76.92%
6 Month
-87.29%
-87.29%
1 Year
-95.33%
-95.33%

More News

Read More
CLDI Stock Earnings: Calidi Biotherapeutics Beats EPS for Q1 2024
Via InvestorPlace
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
From Calidi Biotherapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
From Calidi Biotherapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24
From Calidi Biotherapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
From Calidi Biotherapeutics, Inc.
Via Business Wire
S&P 500 Edges Lower; PacBio Shares Plunge
Via Benzinga
Topics Stocks
Exposures US Equities
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Gold Moves Higher; Morgan Stanley Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Why Calidi Biotherapeutics (CLDI) Shares Are Down Over 50%
Via Benzinga
BZFD Stock: BuzzFeed Is Prepping for a Reverse Stock Split
Via InvestorPlace
Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Calidi Biotherapeutics (CLDI) Stock Down 51% Today?
Via InvestorPlace
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
From Calidi Biotherapeutics, Inc.
Via Business Wire
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024
From Calidi Biotherapeutics, Inc.
Via Business Wire
CLDI Stock Earnings: Calidi Biotherapeutics Misses EPS for Q4 2023
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.